Crossover Study From Macitentan or Bosentan Over to Ambrisentan
Condition(s):Pulmonary Arterial HypertensionLast Updated:April 8, 2019Terminated
Hide Studies Not Open or Pending
Condition(s):Pulmonary Arterial HypertensionLast Updated:April 8, 2019Terminated
Condition(s):Pulmonary Arterial HypertensionLast Updated:June 29, 2022Completed
Condition(s):Pulmonary Arterial HypertensionLast Updated:August 11, 2014Completed
Condition(s):IschemiaLast Updated:May 3, 2013Completed
Condition(s):Pre-Pulmonary Atrial HypertensionLast Updated:January 19, 2021Terminated
Condition(s):Pulmonary Arterial HypertensionLast Updated:November 15, 2019Terminated
Condition(s):Covid19; HypoxemiaLast Updated:March 21, 2023Terminated
Condition(s):Portopulmonary HypertensionLast Updated:January 12, 2021Completed
Condition(s):Portopulmonary HypertensionLast Updated:June 17, 2016Withdrawn
Condition(s):Hypoplastic Left Heart Syndrome; Hypoplastic Right-sided Heart ComplexLast Updated:September 12, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.